At Ab Initio Pharma, we are committed to empowering pharmaceutical companies by offering comprehensive contract development and manufacturing (CDMO) services tailored to complex dosage forms. From early-stage development through to clinical and registration, we specialise in delivering cGMP-compliant solutions that ensure product quality, safety, and regulatory compliance.
Company Details
- Employees
- 19
- Founded
- 2019
- Address
- Camperdown, Nsw 2050, Au
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Inhalation pharmaceuticals, Non-sterile formulations, R&D, CDMO, Complex dosage forms, cGMP.
- HQ
- Camperdown, NSW
Ab Initio Pharma Questions
Ab Initio Pharma's website is https://www.ab-initio-pharma.com/
Ab Initio Pharma's LinkedIn profile is https://au.linkedin.com/company/ab-initio-pharma
Ab Initio Pharma has
19 employees.
View email and phone details for 19
employees at Ab Initio Pharma.
Ab Initio Pharma's industry is
Pharmaceutical Manufacturing
Ab Initio Pharma's top competitors are
Arcs Australia,
Centre For Drug Discovery Innovation,
Endo Axiom,
Ozuk,
Rna Australia,
Ultraceuticals,
Abvance,
Syntara,
Kinoxis Therapeutics Pty Ltd,
Ab Initio Software.
Ab Initio Pharma's categories are Pharmaceutical Manufacturing
Ab Initio Pharma's founding year is 2019
